Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.

Schrader J, Bramlage P, Lüders S, Thoenes M, Schirmer A, Paar DW.

Clin Drug Investig. 2007;27(11):783-96.

PMID:
17914897
2.

Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.

Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.

Clin Drug Investig. 2007;27(8):545-58.

PMID:
17638395
4.

Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.

Chrysant SG, Neutel JM, Ferdinand KC; INCLUSIVE investigators.

J Natl Med Assoc. 2009 Apr;101(4):300-7.

PMID:
19397219
7.

Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.

Sowers JR, Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC, Ofili EO, Weber MA; INCLUSIVE Investigators.

J Clin Hypertens (Greenwich). 2006 Jul;8(7):470-80.

8.
9.

Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.

Cushman WC, Neutel JM, Saunders E, Bakris GL, Ferdinand KC, Ofili EO, Sowers JR, Madder R, Weber MA.

Am J Geriatr Cardiol. 2008 Jan-Feb;17(1):27-36.

PMID:
18174757
10.

Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial.

Ofili EO, Cable G, Neutel JM, Saunders E.

J Womens Health (Larchmt). 2008 Jul-Aug;17(6):931-8. doi: 10.1089/jwh.2008.0499.

11.

A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.

Bobrie G, Delonca J, Moulin C, Giacomino A, Postel-Vinay N, Asmar R; COmparative Study of Efficacy of Irbesartan/HCTZ with Valsartan/HCTZ Using Home Blood Pressure Monitoring in the TreAtment of Mild-to-Moderate Hypertension (COSIMA) Investigators.

Am J Hypertens. 2005 Nov;18(11):1482-8.

PMID:
16280286
13.

The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.

Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC, Ofili EO, Sowers JR, Weber MA; INCLUSIVE Investigators.

J Clin Hypertens (Greenwich). 2005 Oct;7(10):578-86.

14.

Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.

Lee HY, Hong BK, Chung WJ, Lee BK, Lee SH, Jeon DW, Ahn YK, Kim D, Park CK, Kim SH, Jung HO, Kim BO, Choi D.

Clin Ther. 2011 Aug;33(8):1043-56. doi: 10.1016/j.clinthera.2011.07.002. Epub 2011 Aug 10.

PMID:
21831438
16.

A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).

Coca A, Calvo C, García-Puig J, Gil-Extremera B, Aguilera MT, de la Sierra A, Martín-Hidalgo A, Marín R; MAPAVEL Investigators (Monitorizacíon Ambulatoria Presión Arterial APROVEL).

Clin Ther. 2002 Jan;24(1):126-38.

PMID:
11833827
17.

Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.

Agabiti-Rosei E, Manolis A, Zava D, Omboni S; ZODIAC Study Group.

Adv Ther. 2014 Feb;31(2):217-33. doi: 10.1007/s12325-013-0090-8. Epub 2014 Jan 11.

18.

Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension.

Coca A, Calvo C, Sobrino J, Gómez E, López-Paz JE, Sierra C, Bragulat E, de la Sierra A.

Clin Ther. 2003 Nov;25(11):2849-64.

PMID:
14693309
19.

Efficacy and safety of irbesartan/HCTZ in severe hypertension according to cardiometabolic factors.

Franklin SS, Neutel JM.

J Clin Hypertens (Greenwich). 2010 Jul 1;12(7):487-94. doi: 10.1111/j.1751-7176.2010.00294.x.

20.

Supplemental Content

Support Center